A novel prognostic score (HAMP) for head and neck cancer patients with single and multiple SBRT-treated lung metastases derived from retrospective analyses of survival outcome.
Samuel Moritz VorbachThomas SeppiManuel P SarclettiSiegfried KollotzekJulian MangesiusJens LehmannDavid RiedlMartin J PointnerMatthias SanterDaniel DejacoMeinhard Nevinny-StickelUte GanswindtPublished in: Head & neck (2024)
The HAMP score might be a convenient tool to facilitate individualized treatment decisions and appropriate follow-up. The accuracy and reliability of the score requires further evaluation in prospective studies.